Canopy Growth (CGC) Profit After Tax (2019 - 2025)
Canopy Growth (CGC) reported Profit After Tax of -$77.6 million for Q4 2025, down 10.49% on a YoY basis from -$86.7 million in Q4 2024, and down 2044.68% sequentially from -$3.6 million in Q3 2025.
Canopy Growth (CGC) Profit After Tax (2019 - 2025) Analysis & Trends
Canopy Growth (CGC) has 7 years of Profit After Tax data on file, last reported at -$77.6 million in Q4 2025.
- For the quarter ending Q4 2025, Profit After Tax fell 10.49% year-over-year to -$77.6 million; the trailing twelve-month figure through Dec 2025 stood at -$183.8 million (up 7.65% YoY), and the FY2026 full-year result was -$191.7 million, up 46.57% from the prior year.
- Profit After Tax slipped to -$77.6 million in Q4 2025, from -$3.6 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $319.2 million in Q2 2021 to a low of -$1.6 billion in Q2 2022.
- A 5-year average of -$206.5 million and a median of -$82.3 million in 2024 frame the typical range for Profit After Tax.
- Across the five-year window, Profit After Tax soared 507.97% in 2021 and sank 2569.22% in 2022, its largest moves.
- Tracing CGC's Profit After Tax over 5 years: stood at -$91.6 million in 2021, then slumped by 92.97% to -$176.8 million in 2022, then advanced by 14.56% to -$151.1 million in 2023, then jumped by 53.52% to -$70.2 million in 2024, then slipped by 10.49% to -$77.6 million in 2025.
- Business Quant data shows CGC's Profit After Tax at -$77.6 million in Q4 2025, -$3.6 million in Q3 2025, and -$32.4 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 369.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.35 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 274.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Canopy Growth | 197.77 Mn | -68.15 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -77.58 Mn |
| Sep 30, 2025 | -3.62 Mn |
| Jun 30, 2025 | -32.38 Mn |
| Dec 31, 2024 | -70.21 Mn |
| Sep 30, 2024 | -82.26 Mn |
| Jun 30, 2024 | -78.91 Mn |
| Mar 31, 2024 | 32.37 Mn |
| Dec 31, 2023 | -151.07 Mn |
| Sep 30, 2023 | -224.82 Mn |
| Jun 30, 2023 | -28.38 Mn |
| Mar 31, 2023 | -479.03 Mn |
| Dec 31, 2022 | -176.81 Mn |
| Sep 30, 2022 | -234.48 Mn |
| Jun 30, 2022 | -1.64 Bn |
| Mar 31, 2022 | -408.19 Mn |
| Dec 31, 2021 | -91.63 Mn |
| Sep 30, 2021 | -8.78 Mn |
| Jun 30, 2021 | 319.24 Mn |
| Mar 31, 2021 | -487.25 Mn |
| Dec 31, 2020 | -636.08 Mn |